Yifeng Pharmacy (603939) — Capital Reinvestment Ratio
Yifeng Pharmacy (603939) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥641.93 Million) in capital expenditures (CN¥44.81 Million). Check 603939 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yifeng Pharmacy Capital Reinvestment Ratio (2011–2024)
This chart tracks Yifeng Pharmacy's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see 603939 cash generation efficiency.
Annual Capital Reinvestment Ratio for Yifeng Pharmacy (2011–2024)
Year-by-year Capital Reinvestment Ratio for Yifeng Pharmacy from 2011 to 2024. See free cash flow generation of Yifeng Pharmacy to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | CN¥4.22 Billion | CN¥682.67 Million | ▲ +1.9% |
| 2023 | 0.16x | CN¥4.66 Billion | CN¥739.92 Million | ▲ +5.9% |
| 2022 | 0.15x | CN¥3.92 Billion | CN¥587.51 Million | ▼ -61.1% |
| 2021 | 0.38x | CN¥2.15 Billion | CN¥827.54 Million | ▼ -11.8% |
| 2020 | 0.44x | CN¥1.34 Billion | CN¥582.80 Million | ▼ -7.4% |
| 2019 | 0.47x | CN¥963.23 Million | CN¥454.05 Million | ▲ +3.0% |
| 2018 | 0.46x | CN¥510.71 Million | CN¥233.67 Million | ▼ -29.8% |
| 2017 | 0.65x | CN¥317.20 Million | CN¥206.73 Million | ▼ -64.2% |
| 2016 | 1.82x | CN¥139.94 Million | CN¥254.86 Million | ▲ +103.6% |
| 2015 | 0.89x | CN¥181.52 Million | CN¥162.37 Million | ▲ +97.9% |
| 2014 | 0.45x | CN¥212.35 Million | CN¥95.98 Million | ▲ +25.1% |
| 2013 | 0.36x | CN¥156.71 Million | CN¥56.61 Million | ▼ -68.4% |
| 2012 | 1.14x | CN¥80.73 Million | CN¥92.21 Million | ▲ +46.2% |
| 2011 | 0.78x | CN¥122.99 Million | CN¥96.09 Million | — |